Clinical Trial Update: Dimethyl Fumarate for Obstructive Sleep Apnea [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating dimethyl fumarate for Obstructive Sleep Apnea has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

Sponsor: University of Michigan | Conditions: Obstructive Sleep Apnea, OSA | Phase 2 | Status: COMPLETED | Results posted: 2017-05-31